SBF2 and glioblastoma: After confirming that EGFL7 was involved in miR-338-3p-regulated GBM cell-driven angiogenesis, we hypothesized that EGFL7 was a mediator of NFAT5/SBF2-AS1-regualted GBM cell-driven angiogenesis.